Improving the odds for patients with heart pumps
Neurohormonal blockade drug therapy boosts survival and quality of life outcomes for patients with left ventricular assist devices, a Yale study shows.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Brain | Cardiology | Health | Heart | Neurology | Neuroscience | Science | Study | Universities & Medical Training | Yale